english Icono del idioma   español Icono del idioma  

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12008/11111 How cite
Title: Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva
Authors: López Verdín, Sandra
Soto Avila, Juan José
Zamora Pérez, Ana Lourdes
Lazalde Ramos, Blanca Patricia
Martínez Fierro, Margarita de la Luz
González González, Rogelio
Molina Frechero, Nelly
Isiordia Espinoza, Mario Alberto
Bologna Molina, Ronell
Type: Artículo
Issue Date: 2017
Abstract: Background: The objective of this study was to assess the potential clinical value of the concentration of soluble salivary E-cadherin (sE-cadherin) compared with the clinical value of the resence of membranous E-cadherin (mE-cadherin) in oral squamous cell carcinoma tumor tissues. Material and Methods: Data regarding patient demographics, clinical stage, saliva and tumor tissue samples were collected. The saliva was analyzed for sE-cadherin protein levels and was compared to the mE-cadherin immunohistochemical expression levels in tumor tissues, which were assessed via the HercepTest® method. Patients without cancer were included in the study as a control group for comparisons of the sE-cadherin levels. Results: sE-cadherin levels in the saliva of patients without cancer were lower than those in patients with cancer, and the difference was statistically significant (p=0.031). Low mE-cadherin xpression was statistically significantly associated with lymph node positivity (p=0.015) and advanced clinical stage (p=0.001). The inverse relationship between mE-cadherin and sE-cadherin was significant in terms of lymph node positivity (p=0.014) and advanced clinical stage (p=0.037). Background: The objective of this study was to assess the potential clinical value of the concentration of soluble salivary E-cadherin (sE-cadherin) compared with the clinical value of the resence of membranous E-cadherin (mE-cadherin) in oral squamous cell carcinoma tumor tissues. Material and Methods: Data regarding patient demographics, clinical stage, saliva and tumor tissue samples were collected. The saliva was analyzed for sE-cadherin protein levels and was compared to the mE-cadherin immunohistochemical expression levels in tumor tissues, which were assessed via the HercepTest® method. Patients without cancer were included in the study as a control group for comparisons of the sE-cadherin levels. Results: sE-cadherin levels in the saliva of patients without cancer were lower than those in patients with cancer, and the difference was statistically significant (p=0.031). Low mE-cadherin xpression was statistically significantly associated with lymph node positivity (p=0.015) and advanced clinical stage (p=0.001). The inverse relationship between mE-cadherin and sE-cadherin was significant in terms of lymph node positivity (p=0.014) and advanced clinical stage (p=0.037). Background: The objective of this study was to assess the potential clinical value of the concentration of soluble salivary E-cadherin (sE-cadherin) compared with the clinical value of the resence of membranous E-cadherin (mE-cadherin) in oral squamous cell carcinoma tumor tissues. Material and Methods: Data regarding patient demographics, clinical stage, saliva and tumor tissue samples were collected. The saliva was analyzed for sE-cadherin protein levels and was compared to the mE-cadherin immunohistochemical expression levels in tumor tissues, which were assessed via the HercepTest® method. Patients without cancer were included in the study as a control group for comparisons of the sE-cadherin levels. Results: sE-cadherin levels in the saliva of patients without cancer were lower than those in patients with cancer, and the difference was statistically significant (p=0.031). Low mE-cadherin xpression was statistically significantly associated with lymph node positivity (p=0.015) and advanced clinical stage (p=0.001). The inverse relationship between mE-cadherin and sE-cadherin was significant in terms of lymph node positivity (p=0.014) and advanced clinical stage (p=0.037).
Publisher: Medicina Oral
IN: Medicina Oral Patología Oral y Cirugía Bucal, Vol.22, no.6, pp.694-701
Citation: López-Verdín, S., Soto-Avila, J., Zamora-Pérez, A. y otros. "Patients with advanced oral squamous cell carcinoma have high levels of soluble E-cadherin in the saliva". Medicina Oral Patología Oral y Cirugía Bucal [en linea]. 2017, Vol.22, no.6, pp.694-701
License: Licencia Creative Common Atribución (CC-BY)
Appears in Collections:Artículos - Facultad de Odontología

Files in This Item:
File Description SizeFormat  
BolognaMolina_medoralv22_i6_p694.pdf2,45 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons